Coherus Oncology, Inc. (FRA:8C5)
1.116
+0.003 (0.27%)
At close: Nov 28, 2025
-7.27% (1Y)
| Market Cap | 141.77M |
| Revenue (ttm) | 236.71M |
| Net Income (ttm) | 132.08M |
| Shares Out | n/a |
| EPS (ttm) | 1.14 |
| PE Ratio | 1.07 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 455 |
| Open | 1.116 |
| Previous Close | 1.113 |
| Day's Range | 1.116 - 1.116 |
| 52-Week Range | 0.608 - 2.120 |
| Beta | n/a |
| RSI | 46.00 |
| Earnings Date | Mar 4, 2026 |